Our team members are at the heart of everything we do. At Cencora, we are united in our responsibility to create healthier futures, and every person here is essential to us being able to deliver on that purpose. If you want to make a difference at the center of health, come join our innovative company and help us improve the lives of people and animals everywhere. Apply today!

Job Details

Cencora is looking for up to 2 Medical Communications Fellows to join the organization at our headquarters in Conshohocken, PA.

Primary Duties and Responsibilities:

This 2-year, degree-granting Fellowship, sponsored by Cencora, in conjunction with the University of Florida College of Pharmacy, provides a unique research, medical writing, and education experience in a healthcare consulting environment. The Fellow will work on numerous projects in various disease areas, and interact with many of the top pharmaceutical companies, managed care organizations, and healthcare providers throughout the United States and abroad. During the Fellowship, professionals from Cencora will mentor the Fellow in multiple consulting projects with a focus on medical writing and medical communications. This Fellowship places an emphasis on review and evaluation of the medical literature and the healthcare landscape, with the intent of developing various stakeholder communication pieces, including Academy of Managed Care Pharmacy (AMCP) Format formulary dossiers, global value dossiers, scientific publications (eg, posters and manuscripts), and field-based scientific slide decks. In addition, training will be provided on how to systematically review the literature and conduct either qualitative or quantitative analyses. At the conclusion of the Fellowship, a driven Fellow will possess the skills and knowledge necessary to enter a successful career in a consulting firm, pharmaceutical company, managed care organization, or academia. In addition, the Fellow will earn a Master of Science in Pharmaceutical Outcomes and Policy through the University of Florida College of Pharmacy, with an emphasis in Pharmaceutical Value Communications. If desired, the Fellow will also have the option to earn an MBA degree through Stetson University, in conjunction with the University of Florida MS degree.

Fellowship Goals and Objectives:

• To provide the Fellow with training and experience in medical writing, as well as in verbal and written scientific communications
• To enhance the Fellow’s knowledge of literature searching, critical evaluation of study design, and health outcomes research methodologies
• To provide the Fellow with training and experience in data analysis, report writing and presentation of results
• To develop an understanding of pharmaceutical manufacturers’ business and how companies interact with consulting firms to meet their business objectives
• To gain relevant didactic training by completing online coursework through the University of Florida College of Pharmacy

Core Competencies:

• Business Insights
• Collaborates
• Communicates Effectively
• Customer Focus
• Decision Quality
• Drives for Results
• Ensure Accountability
• Functional Knowledge
• Manages Ambiguity
• Manages Complexity 

Minimum Skills and Requirements:

• Although not required, applicable experience, such as consulting and/or pharmaceutical industry experience is preferred.
• Strong interest in medical writing desired.
• Minimum cumulative pharmacy school GPA of 3.0

Application Requirements:

• Letter of Intent/Cover Letter (up to 1 page) addressed to Bridgette Schroader
• Curriculum Vitae/Resume with inclusion of current pharmacy school GPA

Selection Process

Candidates will be selected by our Fellowship Selection Committee from a national pool of individuals who possess a strong interest in medical writing and medical communications.  Although not required, applicable experience, such as an internship in a related field, is preferred. A successful candidate must have earned a PharmD from an Accreditation Counsel for Pharmacy Education (ACPE) accredited college of pharmacy before June 15, 202